Form 4: Generation Bio Co. Director Acquires 60,000 Stock Options

Director Jason P. Rhodes acquired 60,000 stock options in Generation Bio Co. on June 6, 2024, with vesting contingent on future events.

Summary

• Jason P. Rhodes, a director of Generation Bio Co., acquired 60,000 stock options on June 6, 2024.
• The exercise price of these options is $3.32.
• The options vest fully on the earlier of June 6, 2025, or the date of Generation Bio's 2025 annual meeting of stockholders.
• Rhodes is a member of Atlas Venture Associates X, LLC and will transfer any economic benefit from the sale of shares to Atlas Venture Life Science Advisors, LLC.
• He disclaims beneficial ownership except for his pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing an insider transaction. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Future Outlook

The vesting of the options is contingent on future events, specifically the earlier of June 6, 2025, or the date of Generation Bio's 2025 annual meeting of stockholders.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors and their potential alignment with shareholder interests.

Stakeholder Impact

• The transaction could have a minor impact on shareholders by aligning the director's interests with the company's performance.

Key Dates